227 related articles for article (PubMed ID: 7998769)
1. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.
Dyck PJ; Litchy WJ; Kratz KM; Suarez GA; Low PA; Pineda AA; Windebank AJ; Karnes JL; O'Brien PC
Ann Neurol; 1994 Dec; 36(6):838-45. PubMed ID: 7998769
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.
Dyck PJ; Daube J; O'Brien P; Pineda A; Low PA; Windebank AJ; Swanson C
N Engl J Med; 1986 Feb; 314(8):461-5. PubMed ID: 3511382
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
Van Doorn PA
Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
[TBL] [Abstract][Full Text] [Related]
4. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
5. [Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
Iwatsubo T; Sakanaka C; Obi T; Takeda K; Sakuta M
Rinsho Shinkeigaku; 1989 Jul; 29(7):930-2. PubMed ID: 2805518
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
[No Abstract] [Full Text] [Related]
7. The Mayo Clinic experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP).
Dyck PJ; Pineda A; Swanson C; Low P; Windebank A; Daube J
Prog Clin Biol Res; 1982; 106():197-204. PubMed ID: 6757940
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
van der Meché FG; Schmitz PI
N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Dyck PJ; Low PA; Windebank AJ; Jaradeh SS; Gosselin S; Bourque P; Smith BE; Kratz KM; Karnes JL; Evans BA
N Engl J Med; 1991 Nov; 325(21):1482-6. PubMed ID: 1658648
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin.
Choudhary PP; Hughes RA
QJM; 1995 Jul; 88(7):493-502. PubMed ID: 7633875
[TBL] [Abstract][Full Text] [Related]
11. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kumazawa K; Yuasa N; Mitsuma T; Nagamatsu M; Sobue G
Rinsho Shinkeigaku; 1998 Aug; 38(8):719-23. PubMed ID: 9916516
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation.
Taylor BV; Wijdicks EF; Poterucha JJ; Weisner RH
Ann Neurol; 1995 Nov; 38(5):828-31. PubMed ID: 7486876
[TBL] [Abstract][Full Text] [Related]
13. [Chronic inflammatory demyelinating polyradiculoneuropathy].
Jakobsen JK; Lauritzen MJ; Krarup C
Ugeskr Laeger; 1991 Sep; 153(36):2474-7. PubMed ID: 1926597
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
van der Meché FG; van Doorn PA
Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study.
Merkies IS; Bril V; Dalakas MC; Deng C; Donofrio P; Hanna K; Hartung HP; Hughes RA; Latov N; van Doorn PA;
Neurology; 2009 Apr; 72(15):1337-44. PubMed ID: 19365055
[TBL] [Abstract][Full Text] [Related]
16. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
17. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
Imai N; Miyata K; Terayama Y; Ishihara N
Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immune globulin in the Guillain-Barré syndrome.
van der Meché FG
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
[TBL] [Abstract][Full Text] [Related]
19. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
20. A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies.
Pollard JD
Muscle Nerve; 1987; 10(3):214-21. PubMed ID: 3031499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
